Saturday, July 15, 2017
Delivery of p21 saRNA into rectum shows antitumor efficacy in a preclinical study
A recent study published in Biomaterials's ahead of print issue of June reported in vivo efficacy of p21 saRNA delivered intrarectally to mice bearing orthotopic colorectal cancer.